Success Story: EB1A Approved Without RFE For A Nuclear Medicine Expert With Our Expert Guidance
Client’s Testimonial:
"Thanks to your professionalism, clear guidance, and timely support throughout the process, my EB1A I-140 petition was approved smoothly—I truly appreciate your dedication and highly recommend your services.”
On May 16th, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Nuclear Medicine Physician Scientist (Approval Notice).
General Field: Nuclear Medicine
Position at the Time of Case Filing: Assistant Attending
Country of Origin: India
Approval Notice Date: May 16th, 2026
Processing Time: 28 months, 28 days (Premium Processing Upgrade Requested)
Case Summary:
“Therefore, [Client] being able to fulfil this role and deem whose research findings are worthy of widespread distribution affirms her place as a respected figure in the field, and a leading expert in nuclear medicine.”
The statement above is taken from one of four recommendation letters submitted as part of the I-140 EB-1A petition for a nuclear medicine and molecular imaging expert with an M.B.B.S. Our team prepared the petition to demonstrate that the client had risen to the top of her field through original contributions, scholarly authorship, peer review service, national and international recognition, and continued work in an area that would prospectively benefit the United States.
To establish the client’s extraordinary ability, we highlighted objective evidence of her sustained record of influence:
- 27 peer-reviewed scientific articles and 7 book chapters
- 225 citations to her nuclear medicine research
- At least 67 peer reviews for journals in nuclear medicine, imaging, and related fields
The petition did not present these achievements as automatically sufficient. Instead, we explained how an adjudicator could view the record as evidence of sustained acclaim and major significance. The client’s publications showed consistent scholarly productivity, her citation record reflected reliance by other researchers, and her peer review service demonstrated that respected journals trusted her expertise to evaluate the work of others.
A key part of the petition focused on how the client’s research had been used in clinical and scholarly settings. We also emphasized that at least two of her papers ranked among the top 10% most-cited articles in Clinical Medicine for their publication years, further contextualizing her citation record as evidence of field-level reliance rather than raw numerical impact alone.
The four recommendation letters further supported the client’s standing by explaining the importance of her work in nuclear imaging, cancer management, post-transfusion recovery research, and radiology resident education. These letters helped connect the client’s technical contributions to broader improvements in clinical decision-making, imaging-based diagnosis, and healthcare training.
It has been an honor to support this accomplished nuclear medicine expert throughout this EB-1A journey, and we extend our sincere best wishes for her continued success in advancing molecular imaging, radiology, and patient-centered clinical research in the United States.